102ND GENERAL ASSEMBLY
State of Illinois
2021 and 2022
HB3532

 

Introduced 2/22/2021, by Rep. Deb Conroy

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/316.5 new

    Amends the Illinois Controlled Substances Act. Provides that except as otherwise provided in the Act, when issuing a first-time opioid prescription for outpatient use to an adult patient with an acute condition, a medical practitioner shall not issue a prescription for more than a 7-day supply. Provides that except as otherwise provided in the Act, a medical practitioner shall not issue a prescription for an opioid to a minor for more than a 7-day supply at any time and shall discuss with a parent, tutor, or guardian of the minor the risks associated with opioid use and the reasons why the prescription is necessary. Determines when a medical practitioner can prescribe more than a 7-day supply. Provides that a prescription may be filled for less than the prescribed amount.


LRB102 12163 KMF 17500 b

 

 

A BILL FOR

 

HB3532LRB102 12163 KMF 17500 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by adding Section 316.5 as follows:
 
6    (720 ILCS 570/316.5 new)
7    Sec. 316.5. Opioid prescriptions.
8        (1)(a) Except as provided in paragraph (2) of this
9    subsection, when issuing a first-time opioid prescription
10    for outpatient use to an adult patient with an acute
11    condition, a medical practitioner shall not issue a
12    prescription for more than a 7-day supply.
13    (b) Except as provided in paragraph (2) of this
14subsection, a medical practitioner shall not issue a
15prescription for an opioid to a minor for more than a 7-day
16supply at any time and shall discuss with a parent, tutor, or
17guardian of the minor the risks associated with opioid use and
18the reasons why the prescription is necessary.
19        (2) If, in the professional medical judgment of a
20    medical practitioner, more than a seven-day supply of an
21    opioid is required to treat the adult or minor patient's
22    acute medical condition or is necessary for the treatment
23    of chronic pain management, pain associated with a cancer

 

 

HB3532- 2 -LRB102 12163 KMF 17500 b

1    diagnosis, or for palliative care, the practitioner may
2    issue a prescription for the quantity needed to treat the
3    patient's acute medical condition or pain. The condition
4    triggering the prescription of an opioid for more than a
5    seven-day supply shall be documented in the patient's
6    medical record and the practitioner shall indicate that a
7    nonopioid alternative was not appropriate to address the
8    medical condition.
9        (3) This Subsection shall not apply to medications
10    designed for the treatment of substance abuse or opioid
11    dependence.
12        (4) Prior to issuing a prescription for an opioid, a
13    medical practitioner shall do both of the following:
14    (a) Consult with the patient regarding the quantity of the
15opioid and the patient's option to fill the prescription in a
16lesser quantity.
17    (b) Inform the patient of the risks associated with the
18opioid prescribed.
19        (5) (a) A pharmacist filling a prescription for an
20    opioid may dispense the prescribed substance in an amount
21    less than the recommended full quantity indicated on the
22    prescription if requested by the patient and the
23    prescription complies with the provisions of this Section.
24    The patient may request that the pharmacist fill an
25    additional amount not to exceed the remaining prescribed
26    quantity in accordance with 21 U.S.C. 829.

 

 

HB3532- 3 -LRB102 12163 KMF 17500 b

1    (b) If the dispensed amount is less than the recommended
2full quantity, the pharmacist or a designee shall ensure that
3the actual dispensed amount is accurately recorded in the
4prescription monitoring program. The pharmacist or a designee
5shall also, within seven days, make a notation in the
6interoperable electronic health record of the patient if the
7pharmacist has access to the record.
8    (c) Nothing in this Subsection shall be interpreted to
9conflict with or supersede any other requirement established
10in this Section for a prescription of a controlled dangerous
11substance or any requirements or conditions for drug
12substitutions established by law.